Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Pulmonary Diseases
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-11-29.
Trial Details
NCT Number NCT05147688
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Pulmonary Disease, Asthma, Chronic Obstructive Pulmonary Disease
Enrollment 20 participants
Start Date 2021-12-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-17